Acrospire Investment Management LLC - CANCER GENETICS INC ownership

CANCER GENETICS INC's ticker is CGIXXXXX and the CUSIP is 13739U104. A total of 30 filers reported holding CANCER GENETICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Acrospire Investment Management LLC ownership history of CANCER GENETICS INC
ValueSharesWeighting
Q1 2017$45,000
+400.0%
11,090
+69.3%
0.04%
+825.0%
Q4 2016$9,000
+28.6%
6,549
+86.4%
0.00%
-20.0%
Q2 2016$7,0003,5140.01%
Other shareholders
CANCER GENETICS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Timpani Capital Management LLC 206,579$2,847,0001.42%
Sterneck Capital Management, LLC 95,830$1,321,0000.80%
PERKINS CAPITAL MANAGEMENT INC 81,775$1,127,0000.76%
GRUBER & MCBAINE CAPITAL MANAGEMENT LLC 83,900$1,156,0000.30%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 354,180$4,881,0000.25%
WHITE PINE CAPITAL LLC 54,350$748,0000.14%
SSI INVESTMENT MANAGEMENT LLC 62,959$868,0000.08%
DRIEHAUS CAPITAL MANAGEMENT LLC 151,214$2,084,0000.08%
ROTHSCHILD INVESTMENT LLC /IL 31,200$430,0000.06%
ARDSLEY ADVISORY PARTNERS LP 27,500$379,0000.05%
View complete list of CANCER GENETICS INC shareholders